Peter H. Scanlon

What are the perceptions and concerns of people living with diabetes and National Health Service staff around the potential implementation of AI ‐assisted screening for diabetic eye disease?

Kathryn Willis, Royce Shakespeare, Lakshmi Chandrasekaran, Umar Chaudhry et autres

AIMS: To explore attitudes of people living with diabetes (PLD) and healthcare professionals (HCP) towards the use of automated retinal image analysis systems using artificial intelligence (AI) in NHS Diabetic Eye Screening Programmes (DESP) and how these perceptions vary by sociodemographic subgroups. …

gb, us (code pays fourni par la source)

No evidence that tirzepatide can worsen diabetic retinopathy. Reply to Fadini GP [letter]. Reassessing retinopathy risk with tirzepatide therapy. Reply to Zhang N, Wang W, Wan G [letter]

Adam Buckley, Garry D. Tan, Marta Gruszka-Goh, Peter H. Scanlon et autres

ae, gb (code pays fourni par la source)

A thematic analysis of patients’ experiences of receiving treatment for Neovascular age-related macular degeneration (nAMD)

Julie Hapeshi, Samantha Hughes, Martin McKibbin, Peter H. Scanlon

BACKGROUND/OBJECTIVES: A positive patient experience is a key element of quality healthcare but data on the patient experience is rarely collected as part of routine care. This study analysed survey and discussion group comments from patients treated for neovascular AMD (nAMD) treatment …

gb (code pays fourni par la source)

Early worsening of diabetic retinopathy in individuals with type 2 diabetes treated with tirzepatide: a real-world cohort study

Adam Buckley, Garry D. Tan, Marta Gruszka-Goh, Peter H. Scanlon et autres

Abstract Aims/hypothesis Early worsening of diabetic retinopathy (EWDR) has been described during treatment with glucagon-like peptide-1 receptor agonists including subcutaneous semaglutide. Whether EWDR occurs after initiating treatment with the potent glucagon-like peptide 1 / gastric inhibitory polypeptide receptor agonist tirzepatide is unknown. …

ae, gb (code pays fourni par la source)

Generating evidence to support the role of AI in diabetic eye screening: considerations from the UK National Screening Committee

Trystan Macdonald, Zhivko Zhelev, Xiaoxuan Liu, Christopher Hyde et autres

Screening for diabetic retinopathy has been shown to reduce the risk of sight loss in people with diabetes, because of early detection and treatment of sight-threatening disease. There is long-standing interest in the possibility of automating parts of this process through artificial …

gb (code pays fourni par la source)

Effect of the COVID ‐19 pandemic on diabetic retinopathy and referral levels in the English National Health Service Diabetic Eye Screening Programme

Peter H. Scanlon, Charlotte F. E. Norridge, D. Prentis, Naomi Holman et autres

AIMS: The aim was to determine the effect of the COVID-19 pandemic on diabetic retinopathy and referral rates in the English National Health Service (NHS) Diabetic Eye Screening Programme (DESP). METHODS: Non-patient identifiable data are submitted centrally from the 57 regional centres …

gb, ie (code pays fourni par la source)

Evaluating a new camera for diabetic eye disease screening in Afro-Caribbean and Asian populations without pupil dilation

Peter H. Scanlon

Development of a Target Product Profile for an Artificial Intelligence for Use in English Diabetic Eye Screening, a Modified Delphi Consensus Study

Trystan Macdonald, Jacqueline Dinnes, Gregory Maniatopoulos, Ameenat Lola Solebo et autres

gb, ca, us, cn, nl (code pays fourni par la source)

The scanning CONfoCal Ophthalmoscopy foR DIAbetic eye screening (CONCORDIA) study paper 2

Peter H. Scanlon, Marta Gruszka-Goh, Ushna Javed, Anthony Vukic et autres

PURPOSE: To determine if the Eidon white light 60-degree field Scanning Confocal Ophthalmoscope (SCO) camera was safe to use with staged mydriasis in a Diabetic Eye Screening Programme (DESP). METHODS: The trial participants were recruited from people with diabetes attending appointments in …

gb (code pays fourni par la source)

The Scanning CONfoCal Ophthalmoscopy foR DIAbetic eye screening (CONCORDIA) study paper 1

Peter H. Scanlon, Marta Gruszka-Goh, Ushna Javed, Anthony Vukic et autres

OBJECTIVE: This project was to determine the performance of the Zeiss Clarus 700 (Clarus) and the Optos California (Optos) with staged mydriasis in a Diabetic Eye Screening Programme (DESP). METHODS: Trial participants were recruited from people attending appointments in DESP or Virtual …

gb (code pays fourni par la source)

Ensuring sustainability in diabetic retinopathy screening

John D. Smith, David M. Wright, Noemi Lois, Irene Stratton et autres

The UK clinical eye research strategy: refreshing research priorities for clinical eye research in the UK

Rupert Bourne, Malik Moledina, Augusto Azuara‐Blanco, George M. Saleh et autres

OBJECTIVES: To validate and update the 2013 James Lind Alliance (JLA) Sight Loss and Vision Priority Setting Partnership (PSP)'s research priorities for Ophthalmology, as part of the UK Clinical Eye Research Strategy. METHODS: Twelve ophthalmology research themes were identified from the JLA …

gb, Égypte, it (code pays fourni par la source)